Adnan Jamil

Adnan Jamil is a Senior Consultant at Iperion, now part of Deloitte. Iperion’s approach to assessing companies’ IDMP maturity has been standardized and fine-tuned based on leading subject-matter expertise on regulatory information management, data submissions (e.g., IDMP, xEVMPD), and extensive first-hand experience from projects with a broad spectrum of Life Sciences clients.


Assessing IDMP Maturity

How pharma firms assess their readiness for IDMP (Identification of Medicinal Products) is important for meeting compliance requirements and ensuring they are prepared for the digital product information management future, writes Adnan Jamil.